| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |